|
Volumn 541, Issue 7638, 2017, Pages 444-445
|
Epic project to stockpile vaccines
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EBOLA VACCINE;
VACCINE;
COST ANALYSIS;
EPIDEMIOLOGY;
HEALTH CARE;
HEALTH EXPENDITURE;
INNOVATION;
RESPIRATORY DISEASE;
VACCINE;
ZIKA VIRUS DISEASE;
CHIKUNGUNYA;
CRIMEAN CONGO HEMORRHAGIC FEVER;
EBOLA HEMORRHAGIC FEVER;
EPIDEMIC;
HUMAN;
IMMUNE RESPONSE;
LASSA FEVER;
MARBURG HEMORRHAGIC FEVER;
MIDDLE EAST RESPIRATORY SYNDROME;
NIPAH VIRUS INFECTION;
PRIORITY JOURNAL;
RIFT VALLEY FEVER;
SEVERE ACUTE RESPIRATORY SYNDROME;
SHORT SURVEY;
ZIKA FEVER;
ANIMAL;
CORONAVIRUS INFECTIONS;
DISEASE OUTBREAKS;
ECONOMICS;
HEMORRHAGIC FEVER, EBOLA;
HENIPAVIRUS INFECTIONS;
INTERNATIONAL COOPERATION;
NIPAH VIRUS;
SUPPLY AND DISTRIBUTION;
TIME FACTOR;
GERMANY;
JAPAN;
NORWAY;
SWITZERLAND;
ANIMALS;
CORONAVIRUS INFECTIONS;
DISEASE OUTBREAKS;
HEMORRHAGIC FEVER, EBOLA;
HENIPAVIRUS INFECTIONS;
HUMANS;
INTERNATIONAL COOPERATION;
LASSA FEVER;
NIPAH VIRUS;
TIME FACTORS;
VACCINES;
|
EID: 85016160304
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature.2017.21329 Document Type: Short Survey |
Times cited : (15)
|
References (0)
|